Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| BI 653048 | C23H25F4N3O4S | 1198784-72-3 | Details |
| BI 653048 phosphate | C23H28F4N3O8PS | 1198784-97-2 | Details |
| BI-9321 | C22H21FN4 | 2387510-86-1 | Details |
| BI-749327 | C23H21F3N4O2 | 2361241-23-6 | Details |
| BIBO3304 TFA | C31H36F3N7O5 | 191868-14-1 | Details |
| BIBP3226 TFA | C29H32F3N5O5 | 1068148-47-9 | Details |
| Tolbutamide；HLS 831 | C12H18N2O3S | 64-77-7 | Details |
| BI-9321 trihydrochloride | C22H22ClFN4 | 2387510-87-2 | Details |
| Bithionol sulfoxide | C12H6Cl4O3S | 844-26-8 | Details |
| Bisindolylmaleimide X hydrochloride；Ro31-8425 hydrochloride;BIM-X hydrochloride | C26H25ClN4O2 | 145317-11-9 | Details |
| Bisindolylmaleimide VIII acetate；Bis VIII acetate;Ro 31-7549 acetate | C24H22N4O2 | 138516-31-1 | Details |
| Ifosfamide；NSC109724;Isophosphamide | C7H15Cl2N2O2P | 3778-73-2 | Details |
| BioE-1115 | C19H18FN3O2 | 1268863-35-9 | Details |
| Biotin-VAD-FMK | C30H49FN6O8S | 1135688-15-1 | Details |
| BIO-32546 | C28H31F6NO3 | 1548743-66-3 | Details |
| bio-THZ1 | C52H65ClN12O8S | 1604811-14-4 | Details |
| BIIL-260 hydrochloride | C30H31ClN2O3 | 192581-24-1 | Details |
| Bifeprunox | C24H23N3O2 | 350992-10-8 | Details |
| Bicyclomycin benzoate；FR2054 | C19H22N2O8 | 37134-40-0 | Details |
| Bitopertin (R enantiomer)；RG1678 (R enantiomer);RO4917838 (R enantiomer);Bitopertin R enantiomer | C21H20F7N3O4S | 845614-12-2 | Details |
| Bixin | C25H30O4 | 6983-79-5 | Details |
| BIX-01338 hydrate；BIX 01338 hydrate;BIX01338 hydrate | C32H26F3N3O7 | 1228184-65-3 | Details |
| BI-2852 | C31H28N6O2 | 2375482-51-0 | Details |
| Mebeverine hydrochloride；Duspatal Hydrochloride;Colofac Hydrochloride;Duspatalin Hydrochloride | C25H35NO5.ClH | 2753-45-9 | Details |
| BF 227 | C16H16FN3O2S | 845647-80-5 | Details |
| BGB-102；JNJ-26483327 | C22H25BrN4O2 | 807640-87-5 | Details |
| BI-1408 | C22H23FN6 | 2231075-94-6 | Details |
| Bexarotene D4；LGD1069 D4 | C24H24D4O2 | 2182068-00-2 | Details |
| BF-168 | C18H17FN2O2 | 634911-47-0 | Details |
| Betrixaban-d6；Betrixaban D6 | C23H22ClN5O3 | 2098655-51-5 | Details |
| β-NF-JQ1 | C45H42ClN5O6S | 2380000-55-3 | Details |
| β-Cryptoxanthin；(3R)-β-Cryptoxanthin | C40H56O | 472-70-8 | Details |
| FR252384 | C18H17N3 | 447405-11-0 | Details |
| Anti-Heart Failure Agent 1 | C11H11FN2O3S | 142648-47-3 | Details |
| Beperidium iodide；SX 810 | C23H34N3O3.I | 86434-57-3 | Details |
| BET-BAY 002 | C22H18ClN5O | 1588521-78-1 | Details |
| I-BET282；BET-IN-1 | C25H30N4O4 | 1422554-34-4 | Details |
| BET-IN-2 | C23H29N3O | 2104688-91-5 | Details |
| Proglumide；Xylamide;Binoside | C18H26N2O4 | 6620-60-6 | Details |
| β3-AR agonist 1 | C22H28N4O4S | 1283125-73-4 | Details |
| ODM-207；ODM207;BET-IN-4 | C22H21N3O3 | 1801503-93-4 | Details |
| Benzothiohydrazide | C7H8N2S | 20605-40-7 | Details |
| Prenyl-IN-1 | C28H24ClN5O2 | 360561-53-1 | Details |
| Anti-hypertensive sulfonanilide 1 | C35H37ClN5O6S2 | 129280-22-4 | Details |
| CB1 antagonist 1 | C26H22Cl2N4 | 890037-68-0 | Details |
| Xanthine oxidase-IN-1；4-(3-Cyano-5,6-difluoroindol-1-yl)-2-hydroxybenzoic acid | C16H8F2N2O3 | 1071970-13-2 | Details |
| Retinoic acid；ATRA;all-trans-Retinoic acid;Tretinoin;Vitamin A acid | C20H28O2 | 302-79-4 | Details |
| Antibacterial compound 1 | C14H16FN3O4 | 232951-56-3 | Details |
| 5-HT2A antagonist 1 | C26H28N4O2 | 204643-75-4 | Details |
| H3 receptor-MO-1 | C20H27N3O2 | 1240914-03-7 | Details |
| YM158 free base；YM-57158 | C32H33ClN6O5S2 | 179102-65-9 | Details |
| Benzcyclane；Benzcyclan;Bencyclane | C19H31NO | 2179-37-5 | Details |
| ACAT-IN-1 cis isomer | C29H25NO2 | 145961-79-1 | Details |
| Implitapide Racemate | C35H37N3O2 | 177277-99-5 | Details |
| PPARα-MO-1 | C27H37NO5 | 810677-36-2 | Details |
| PPAR agonist 1 | C20H25NO6S | 539813-69-9 | Details |
| GPR40 Agonist 2 | C24H30O3 | 1147729-48-3 | Details |
| Asthma relating compound 1 | C17H19N3O3S2 | 120165-51-7 | Details |
| Oxybutynin；Oxytrol;Oxibutyninum;Ditropan | C22H31NO3 | 5633-20-5 | Details |
| Prazosin hydrochloride；Peripress;Minipress;Vasoflex;cp-12299-1;Prazosin HCl | C19H22ClN5O4 | 19237-84-4 | Details |
| Benralizumab；MEDI-563;BIW-8405 | 1044511-01-4 | Details |
| BD-AcAc 2；Ketone Ester | C8H16O4 | 1208313-97-6 | Details |
| Beclabuvir；BMS-791325 | C36H45N5O5S | 958002-33-0 | Details |
| Beclomethasone 17-propionate；17-BMP;Beclomethasone-17-monopropionate | C25H33ClO6 | 5534-18-9 | Details |
| Befiradol；F13640;NLX-112 | C20H22ClF2N3O | 208110-64-9 | Details |
| Bencianol；ZY15051 | C28H22O6 | 85443-48-7 | Details |
| Galidesivir；BCX4430;Immucillin-A | C11H15N5O3 | 249503-25-1 | Details |
| Galidesivir hydrochloride；Immucillin-A hydrochloride;BCX 4430 hydrochloride | C11H16ClN5O3 | 222631-44-9 | Details |
| (S)-ML753286 | C20H25N3O3 | 1699720-85-8 | Details |
| Oxybutynin chloride；Oxybutynin HCl;Oxybutynin hydrochloride | C22H32ClNO3 | 1508-65-2 | Details |
| BCI hydrochloride；(E)-BCI hydrochloride | C22H24ClNO | 95130-23-7 | Details |
| BCL6-IN-3 | C24H31ClF2N6O2 | 2253878-44-1 | Details |
| BCR-ABL-IN-1 | C23H21F4N5O | 188260-50-6 | Details |
| BCR-ABL-IN-2 | C24H25Cl2N5O3 | 897369-18-5 | Details |
| BCL2-IN-1 | C47H54ClN7O7S | 1257044-75-9 | Details |
| PROTAC Bcl2 degrader-1 | C45H45BrN6O10S | 2378801-85-3 | Details |
| BCI；(E)-BCI | C22H23NO | 1245792-51-1 | Details |
| Lisaftoclax；Bcl-2/Bcl-xl inhibitor 1 | C45H48ClN7O8S | 2180923-05-9 | Details |
| BB-Cl-Amidine | C26H26ClN5O | 1802637-39-3 | Details |
| Bay 41-4109 | C18H13ClF3N3O2 | 298708-81-3 | Details |
| BAY 73-6691 racemate | C15H12ClF3N4O | 794568-90-4 | Details |
| BAY 73-6691；(R)-BAY 73-6691 | C15H12ClF3N4O | 794568-92-6 | Details |
| Bay 41-4109 (less active enantiomer) | C18H13ClF3N3O2 | 476617-51-3 | Details |
| Estradiol；17β-Estradiol;β-Estradiol;17β-Oestradiol;E2 | C18H24O2 | 50-28-2 | Details |
| BAY885 | C25H28F3N7O2 | 2307249-33-6 | Details |
| BAY-Y 3118 | C20H21ClFN3O3 | 151213-16-0 | Details |
| BAY-985 | C27H30F3N9O | 2409479-29-2 | Details |
| BAY-784 | C29H26ClF4N3O5S2 | 1631164-24-3 | Details |
| BAY-7598 | C28H31N3O6 | 1816257-74-5 | Details |
| BAY-677 | C20H15F3N4O2 | 2117404-84-7 | Details |
| BAY 60-2770 | C35H33F4NO5 | 1027642-43-8 | Details |
| Bay 65-1942 (R form)；Bay 65-1942 R form | C22H25N3O4 | 758683-21-5 | Details |
| Bay 65-1942 free base | C22H25N3O4 | 600734-02-9 | Details |
| BAY-678 | C20H15F3N4O2 | 675103-36-3 | Details |
| Atuveciclib Racemate；BAY-1143572 Racemate | C18H18FN5O2S | 1414943-88-6 | Details |
| BAY-1816032 | C27H24F2N6O4 | 1891087-61-8 | Details |
| Bavisant dihydrochloride hydrate；JNJ31001074AAC | C19H30ClN3O3 | 1103522-80-0 | Details |
| Bax inhibitor peptide V5；BIP-V5;BAX Inhibiting Peptide V5 | C27H50N6O6S | 579492-81-2 | Details |
| Bavisant dihydrochloride | C19H28ClN3O2 | 929622-09-3 | Details |
| BAY-1797 | C20H17ClN2O4S | 2055602-83-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 | ||||